GC
Grimes & Company’s Iterum Therapeutics ITRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,641
| Closed | -$24K | – | 302 |
|
|
2022
Q3 | $24K | Sell |
14,641
-164,755
| -92% | -$270K | ﹤0.01% | 268 |
|
|
2022
Q2 | $36K | Buy |
179,396
+3,120
| +2% | +$626 | ﹤0.01% | 270 |
|
|
2022
Q1 | $63K | Buy |
176,276
+29,438
| +20% | +$10.5K | ﹤0.01% | 295 |
|
|
2021
Q4 | $58K | Sell |
146,838
-12,071
| -8% | -$4.77K | ﹤0.01% | 296 |
|
|
2021
Q3 | $89K | Buy |
158,909
+12,631
| +9% | +$7.07K | ﹤0.01% | 296 |
|
|
2021
Q2 | $338K | Buy |
146,278
+21,641
| +17% | +$50K | 0.01% | 230 |
|
|
2021
Q1 | $176K | Buy |
124,637
+52,637
| +73% | +$74.3K | 0.01% | 270 |
|
|
2020
Q4 | $71K | Buy |
+72,000
| New | +$71K | ﹤0.01% | 263 |
|